Blog
EQS-News: Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
EQS-News: Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
EQS-News: Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE
EQS-News: Steinhoff International Holdings N.V. in liquidatie: DE-LISTING TIMELINE
RM plc: Holding(s) in Company
RM plc: Holding(s) in Company
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS-Adhoc: GRAMMER Aktiengesellschaft: Earnings development deviates from the previous year's level in the third quarter of 2023
EQS-Adhoc: GRAMMER Aktiengesellschaft: Earnings development deviates from the previous year's level in the third quarter of 2023
Amundi Asset Management: AMUNDI ETF – Important Information – Name Changes – 11/10/2023
Amundi Asset Management: AMUNDI ETF – Important Information – Name Changes – 11/10/2023
thyssenkrupp nucera and Neste Sign Agreement to Reserve Production Capacities for 120 MW Water Electrolyser at Neste’s Refinery in Finland
thyssenkrupp nucera and Neste Sign Agreement to Reserve Production Capacities for 120 MW Water Electrolyser at Neste’s Refinery in Finland
EQS-News: Vossloh Aktiengesellschaft: Vossloh introduces the platform Vossloh connect with innovative digital solutions transforming the railway industry
EQS-News: Vossloh Aktiengesellschaft: Vossloh introduces the platform Vossloh connect with innovative digital solutions transforming the railway industry
EQS-News: USU listed in the Gartner® Market Guide for Software Asset Management Tools 2023
EQS-News: USU listed in the Gartner® Market Guide for Software Asset Management Tools 2023
u-blox AG: u-blox introduces new functionally safe end-to-end positioning solution for autonomous driving
u-blox AG: u-blox introduces new functionally safe end-to-end positioning solution for autonomous driving
EQS-News: DATAGROUP SE: 2023 Lünendonk Study: Hybrid IT landscapes are a key topic in the sourcing market
EQS-News: DATAGROUP SE: 2023 Lünendonk Study: Hybrid IT landscapes are a key topic in the sourcing market
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
EQS-News: Energiekontor AG: Energiekontor submits successful bid in British tender process for five Scottish wind park projects
EQS-News: Energiekontor AG: Energiekontor submits successful bid in British tender process for five Scottish wind park projects
EQS-News: DEFENCE ANNOUNCES PEER-REVIEWED PUBLICATION OF ITS PRECLINICAL DATA ON ACCUM® AS AN ANTI-CANCER MOLECULE IN THE JOURNAL OF CANCER SCIENCE
EQS-News: DEFENCE ANNOUNCES PEER-REVIEWED PUBLICATION OF ITS PRECLINICAL DATA ON ACCUM® AS AN ANTI-CANCER MOLECULE IN THE JOURNAL OF CANCER SCIENCE
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: Pyrum Innovations AG continues international expansion - Construction of fifth Pyrum pyrolysis plant planned in Czech Republic
EQS-News: Pyrum Innovations AG continues international expansion - Construction of fifth Pyrum pyrolysis plant planned in Czech Republic
Cairn Homes Plc: Chief Financial Officer to Step Down in 2024
Cairn Homes Plc: Chief Financial Officer to Step Down in 2024
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: ABOUT YOU Holding SE: ABOUT YOU on Track: Accelerated Growth and Significant Margin Improvement
EQS-News: SNP stays on its growth path after best Q3 results ever
EQS-News: SNP stays on its growth path after best Q3 results ever
EQS-News: Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
EQS-News: Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
Lepermislibre: lePERMISLIBRE launches a new unique and unprecedented offer in the driving school market: The “Driving License Insurance”
Lepermislibre: lePERMISLIBRE launches a new unique and unprecedented offer in the driving school market: The “Driving License Insurance”
Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)
Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone


